{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:04:33Z","timestamp":1789535073515,"version":"build-2803163510"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["RS-2025-0221386"],"award-info":[{"award-number":["RS-2025-0221386"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Advanced therapy medicinal products (ATMPs), particularly immune cell therapies, present distinctive regulatory challenges due to biological variability, evolving manufacturing processes, and uncertainty throughout the product lifecycle. Existing competency frameworks for regulatory science are predominantly generalist and may not adequately capture the domain-specific competencies required for immune cell therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop and validate a consensus-based competency framework for regulatory science professionals in immune cell therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      An exploratory sequential mixed-methods design was employed, comprising a multi-source literature review, preliminary expert consultation, semi-structured expert interviews, and a two-round Delphi consensus process. Experts representing academia, industry, regulatory authorities, and government\/public-sector organizations participated in the preliminary consultation and interviews (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911) and the Delphi consensus process (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920). Qualitative data were analyzed using reflexive thematic analysis. Delphi responses were analyzed using descriptive statistics, the content validity ratio, and the item-level content validity index to assess content validity in Round 1, and retention agreement, importance, educational applicability, and measurability in Round 2.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The final framework comprised nine core competencies and 32 sub-competencies organized into three areas: Scientific and Regulatory Foundations, Strategic Application of Regulatory Science, and Regulatory Leadership and Responsibility. High retention agreement (95%\u2013100%) indicated the stability of the framework. Sub-competencies related to leadership, ethics, and higher-order judgment received relatively lower ratings for educational applicability and measurability but were retained because of their conceptual importance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study presents a domain-specific competency framework that conceptualizes regulatory competence in immune cell therapy as an integrative and adaptive capability. The framework provides a practical foundation for competency-based training, assessment, and regulatory science workforce development in immune cell therapy and related ATMPs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1917978","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:32:27Z","timestamp":1789533147000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Developing and validating a regulatory science competency framework for immune cell therapy: a mixed-methods study"],"prefix":"10.3389","volume":"13","author":[{"given":"Jung-A","family":"Lee","sequence":"first","affiliation":[{"name":"College of Pharmacy, Seoul National University","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.omtm.2018.10.003","article-title":"Challenges in advanced therapy medicinal product development: a survey among companies in Europe","volume":"11","author":"ten Ham","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1707741","DOI":"10.3389\/fdgth.2026.1707741","article-title":"Defining core competencies for advanced therapy medicinal products translation","volume":"8","author":"Guillen","year":"2026","journal-title":"Front Digit Health"},{"key":"B3","volume-title":"EMA regulatory science to 2025: strategic reflection","year":"2020"},{"key":"B4","volume-title":"Advancing Regulatory Science for Public Health: A Framework for FDA\u2019s Regulatory Science Initiative","year":"2010"},{"key":"B5","year":"2020"},{"key":"B6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.36000\/HBT.OH.2024.22.164","article-title":"A bright future for immunotherapy: CAR T-cell therapy promises revolutionary changes","volume":"22","author":"Rybachuk","year":"2024","journal-title":"Healthbook Times Oncol Hematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2147\/ITT.S519616","article-title":"Current advances and challenges in CAR-T therapy for hematological and solid tumors","volume":"14","author":"Zhang","year":"2025","journal-title":"Immunotargets Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jcyt.2012.10.008","article-title":"Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry","volume":"15","author":"Bravery","year":"2013","journal-title":"Cytotherapy"},{"key":"B9","first-page":"1","article-title":"Addressing challenges in meeting chemistry, manufacturing and control regulatory requirements for gene therapy products","volume":"5","author":"Magers","year":"2019","journal-title":"Cell Gene Ther Insights"},{"key":"B10","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1056\/NEJMsr1715626","article-title":"Balancing safety and innovation for cell-based regenerative medicine","volume":"378","author":"Marks","year":"2018","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/sctm.18-0156","article-title":"Concise review: lessons learned from islet transplant clinical trials in developing stem cell therapies for type 1 diabetes","volume":"8","author":"Welsch","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.omtm.2021.04.001","article-title":"Global regulatory progress in delivering on the promise of gene therapies for unmet medical needs","volume":"21","author":"Drago","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"855100","DOI":"10.3389\/fmed.2022.855100","article-title":"A regulatory risk-based approach to ATMP\/CGT development: integrating scientific challenges with current regulatory expectations","volume":"9","author":"Salazar-Fontana","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B14","year":"2020"},{"key":"B15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.32429\/jkshp.2024.41.4.005","article-title":"A comparative study of international regulatory framework for anti-cancer immune cell therapies","volume":"68","author":"Kim","year":"2024","journal-title":"Yakhak Hoeji"},{"key":"B16","year":"2025"},{"key":"B17","year":"2025"},{"key":"B18","year":"2026"},{"key":"B19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/cts.12298","article-title":"Advancing a vision for regulatory science training","volume":"8","author":"Adamo","year":"2015","journal-title":"Clin Transl Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.17480\/psk.2023.67.4.231","article-title":"The assessment of educational needs in the industry for training professionals in the regulatory affairs of pharmaceuticals on the competency and knowledge","volume":"67","author":"Lee","year":"2023","journal-title":"Yakhak Hoeji"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21423\/jrs-v08moghissi","article-title":"Regulatory science education: the need for generalization","volume":"8","author":"Moghissi","year":"2020","journal-title":"J Regul Sci"},{"key":"B22","year":"2021"},{"key":"B23","volume-title":"Global Competency Framework for Regulators of Medicines","year":"2023"},{"key":"B24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1001\/jama.287.2.226","article-title":"Defining and assessing professional competence","volume":"287","author":"Epstein","year":"2002","journal-title":"JAMA"},{"key":"B25","first-page":"262","article-title":"Two courses of expertise","volume-title":"Child Development and Education in Japan","author":"Hatano","year":"1986"},{"key":"B26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.edurev.2014.03.001","article-title":"How experts deal with novel situations: a review of adaptive expertise","volume":"12","author":"Bohle Carbonell","year":"2014","journal-title":"Educ Res Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3109\/0142159X.2010.501190","article-title":"Competency-based medical education: theory to practice","volume":"32","author":"Frank","year":"2010","journal-title":"Med Teach"},{"key":"B28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1478-4491-10-43","article-title":"The promise of competency-based education in the health professions for improving global health","volume":"10","author":"Gruppen","year":"2012","journal-title":"Hum Resour Health"},{"key":"B29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3109\/0142159X.2010.500704","article-title":"The role of assessment in competency-based medical education","volume":"32","author":"Holmboe","year":"2010","journal-title":"Med Teach"},{"key":"B30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jcyt.2023.12.005","article-title":"Academic challenges on advanced therapy medicinal products\u2019 development: a regulatory perspective","volume":"26","author":"Olesti","year":"2024","journal-title":"Cytotherapy"},{"key":"B31","volume-title":"Designing and Conducting Mixed Methods Research","author":"Creswell","year":"2018"},{"key":"B32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/nur.20362","article-title":"What\u2019s in a name? Qualitative description revisited","volume":"33","author":"Sandelowski","year":"2010","journal-title":"Res Nurs Health"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1108\/02621710810840730","article-title":"Competencies in the 21st century","volume":"27","author":"Boyatzis","year":"2008","journal-title":"J Manag Dev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/1467-9280.00065","article-title":"Identifying competencies with behavioral-event interviews","volume":"9","author":"McClelland","year":"1998","journal-title":"Psychol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1258\/jhsrp.2007.007074","article-title":"The quality of mixed methods studies in health services research","volume":"13","author":"O'Cathain","year":"2008","journal-title":"J Health Serv Res Policy"},{"key":"B36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","article-title":"Purposeful sampling for qualitative data collection and analysis in mixed method implementation research","volume":"42","author":"Palinkas","year":"2015","journal-title":"Adm Policy Ment Health Ment Health Serv Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","article-title":"Research guidelines for the Delphi survey technique","volume":"32","author":"Hasson","year":"2000","journal-title":"J Adv Nurs"},{"key":"B38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s43441-023-00609-y","article-title":"A modified Delphi study to establish essential clinical pharmacology competencies","volume":"58","author":"Johnson-Williams","year":"2024","journal-title":"Ther Innov Regul Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/2159676X.2019.1628806","article-title":"Reflecting on reflexive thematic analysis","volume":"11","author":"Braun","year":"2019","journal-title":"Qual Res Sport Exerc Health"},{"key":"B41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","article-title":"Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies","volume":"67","author":"Diamond","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1177\/0269216317690685","article-title":"Guidance on conducting and reporting Delphi studies (CREDES) in palliative care: recommendations based on a methodological systematic review","volume":"31","author":"J\u00fcnger","year":"2017","journal-title":"Palliat Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1744-6570.1975.tb01393.x","article-title":"A quantitative approach to content validity","volume":"28","author":"Lawshe","year":"1975","journal-title":"Personnel Psychol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.tips.2017.12.006","article-title":"Regulatory science\u2014an underappreciated component of translational research","volume":"39","author":"Rouse","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"B45","first-page":"1","article-title":"Efficiency and innovation in transfer","volume-title":"Transfer of Learning from a Modern Multidisciplinary Perspective","author":"Schwartz","year":"2005"},{"key":"B46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3389\/fimmu.2012.00253","article-title":"Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development","volume":"3","author":"Ancans","year":"2012","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/j.1365-2923.2007.02912.x","article-title":"Cognitive metaphors of expertise and knowledge: prospects and limitations for medical education","volume":"41","author":"Mylopoulos","year":"2007","journal-title":"Med Educ"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/j.1365-2929.2005.02341.x","article-title":"Entrustability of professional activities and competency-based training","volume":"39","author":"ten Cate","year":"2005","journal-title":"Med Educ"},{"key":"B49","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/0142159X.2017.1315082","article-title":"Core principles of assessment in competency-based medical education","volume":"39","author":"Lockyer","year":"2017","journal-title":"Med Teach"},{"key":"B50","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/0142159X.2012.652239","article-title":"A model for programmatic assessment fit for purpose","volume":"34","author":"van der Vleuten","year":"2012","journal-title":"Med Teach"},{"key":"B51","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/ACM.0000000000000549","article-title":"Linking simulation-based educational assessments and patient-related outcomes: a systematic review and meta-analysis","volume":"90","author":"Brydges","year":"2015","journal-title":"Acad Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/ACM.0000000000001323","article-title":"Fostering the development of master adaptive learners: a conceptual model to guide skill acquisition in medical education","volume":"92","author":"Cutrer","year":"2017","journal-title":"Acad Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s10459-019-09946-w","article-title":"The development of competency frameworks in healthcare professions: a scoping review","volume":"25","author":"Batt","year":"2020","journal-title":"Adv Health Sci Educ Theory Pract"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1917978\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:32:37Z","timestamp":1789533157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1917978\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":53,"alternative-id":["10.3389\/fmed.2026.1917978"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1917978","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1917978"}}